ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.261,34
0,53%
S&P 500
5.487,03
0,25%
US Dollar vs BRL
5,4237
0,00%
Bitcoin
65.195,30
0,35%
Brent Oil
84,585
-0,13%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Theratechnologies Inc (THTX)

  7. Theratechnologies Inc (THTX) Notícias

THTX Theratechnologies Inc

1,32
0,03 (2,33%)
19 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Theratechnologies Inc THTX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,03 2,33% 1,32 01:00:03
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,25 1,25 1,37 1,32 1,29
mais cotações »

Notícias Recentes

Data Hora Fonte Título
23/05/202418:00GLOBETheratechnologies’ Sudocetaxel Zendusortide ASCO 2024..
09/05/202417:30GLOBETheratechnologies Reports on its Annual Meeting of..
02/05/202408:30GLOBETheratechnologies to Present Long-Term Efficacy, Safety and..
15/04/202417:15GLOBETheratechnologies Announces Mailing of Management Proxy..
11/04/202408:30GLOBETheratechnologies to Present at the 2024 Bloom Burton & Co...
10/04/202408:30GLOBETheratechnologies Reports Financial Results and Provides..
10/04/202408:15IHMARKETNEWSU.S. Index Futures Show Mixed Trend Ahead of Key Inflation..
08/04/202417:30GLOBETheratechnologies Preclinical Data Presentation at AACR 2024..
05/04/202412:00GLOBETheratechnologies Appoints Elina Tea to its Board of..
03/04/202408:30GLOBETheratechnologies to Announce First Quarter 2024 Financial..
28/03/202408:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
22/03/202410:36GLOBETheratechnologies Announces Update on its Preclinical..
21/03/202421:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
21/03/202408:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
29/02/202418:34GLOBETheratechnologies Announces the Resignation of One of Its..
27/02/202409:30GLOBETheratechnologies Receives Refusal to File Letter for..
21/02/202409:30GLOBETheratechnologies Reports Financial Results for the Fourth..
20/02/202409:30GLOBETheratechnologies Announces Publication in Frontiers in..
15/02/202409:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
06/02/202409:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
24/01/202409:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
23/01/202409:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
02/01/202411:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
02/01/202409:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
21/12/202318:12PRNCATheratechnologies annonce le renouvellement de son..
21/12/202318:09PRNUSTheratechnologies Announces Renewal of Shelf Prospectus and..
13/12/202309:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
24/11/202309:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
31/10/202313:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
26/10/202309:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
25/10/202317:13GLOBETheratechnologies Announces Proposed Public Offering of..
24/10/202308:00GLOBETheratechnologies Announces Operational Update
19/10/202308:30GLOBETheratechnologies’ Ibalizumab Demonstrates..
16/10/202308:30GLOBETheratechnologies Announces Finalization of Amendments to..
13/10/202308:30GLOBETheratechnologies Presents Data at ID Week Showing..
13/10/202308:00GLOBETheratechnologies Announces Results from Trogarzo®..
12/10/202308:30GLOBETheratechnologies Announces Dosing of First Patient in..
04/10/202308:30GLOBETheratechnologies Receives January 2024 PDUFA Goal Date for..
26/09/202308:34IHMARKETNEWSTuesday’s Wall Street Highlights: Ford Motor, Coty,..
26/09/202308:30GLOBETheratechnologies Reports Financial Results for the Third..
25/09/202308:30GLOBETheratechnologies Announces Agreement in Principle with..
25/09/202308:00GLOBETheratechnologies Submits Tesamorelin F8 Formulation sBLA..
20/09/202308:00GLOBETheratechnologies to Present at the Cantor Fitzgerald Global..
18/09/202317:15GLOBETheratechnologies to Announce Third Quarter 2023 Financial..
07/09/202314:57GLOBETheratechnologies to Present at the H.C. Wainwright 25th..
05/09/202308:00GLOBETheratechnologies Announces Certain Preliminary Q3 2023..
30/08/202311:34GLOBETheratechnologies Announces All U.S. Oncology Clinical Sites..
31/07/202310:00APSBiopharma Firm Completes Reverse Stock Split
31/07/202308:00GLOBETheratechnologies Completes 1-for-4 Reverse Stock Split
28/07/202317:44GLOBETheratechnologies Announces Amendments to its Term Loan..

Seu Histórico Recente

NASDAQ
THTX
Theratechnologies
BIT
NSCIT2880986
IBRD
BIT
S32121
Societe Generale Effekten
LSE
JRIC
Japan Residential ORD 10P
NYSE
WHD
Cactus
NASDAQI
B10GI
OMX Baltic Technology GI
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados